Drug Shortage Report for JAMP-RISPERIDONE
Report ID | 207292 |
Drug Identification Number | 02454319 |
Brand name | JAMP-RISPERIDONE |
Common or Proper name | Risperidone |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 30 mL |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-10-16 |
Estimated end date | 2024-05-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-11-15 |
Company comments | Increase in demand / Allocations |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-11-15 | French | Compare |
v3 | 2023-11-15 | English | Compare |
v2 | 2023-10-18 | French | Compare |
v1 | 2023-10-18 | English | Compare |
Showing 1 to 4 of 4